News archive

Delårsrapport 1 JULI – 30 SEPTEMBER 2022
Läs rapporten PDF (in Swedish) här

(26-October-2022)

Delårsrapport 1 april – 30 juni 2022
Läs rapporten PDF (in Swedish) här

(26-August-2022)

A quick personal Friday update from founder and CEO Dorte X. Gram! We hope you all have a great weekend! 🙏🏼🧡💊

Please, find the link to the video (in English) on Linkedin or Facebook

(17-June-2022)

🇩🇰 🤝🏼 🇸🇪
We’re delighted to be back at the wonderful Børsen with Dansk Erhverv, Medicon Valley Alliance Øresundsinstituttet next Monday, May 30th to discuss regional success, collaboration, challenges and more! 🟠

(23-May-2022)

Dorte’s presentation from last weeks visit to Redeye Investor forum is now online. Please find a link below for a brief update and a good Q&A

Please, find the link to the video (in English) here

(16-May-2022)

Our friends at BIOSTOCK caught our CEO Dorte X. Gram for some comments regarding our good Q1 results and our Orphan Drug Designation request!

Have a read in both English and Swedish 😃

(06-May-2022)

Late last week Redeye had a brief interview with our CEO, Dorte X. Gram regarding the last quarterly report and recent significant changes and developments in Pila.

Please, find the link to the video (in English) here

(03-May-2022)

Delårsrapport 1 januari – 31 mars 2022
Läs rapporten PDF (in Swedish) här

(26-April-2022)

We’re really proud that Malmö stad has selected us as finalist in the Life Science category for the Malmö Business Price Award 2022.

Here, our CEO Dorte X. Gram first found high-risk-investors who dared thinking big and PILA PHARMA was kicked off to provide a future better treatment of diabetes!

Läs (in Swedish) här

(05-April-2022)

Årsredovisning för 2021
Läs rapporten PDF (in Swedish) här

(23-March-2022)

Making progress and keeping steady!
The recording of our CEO Dorte X. Gram’s presentation (in Swedish) from Aktiespararna is now live.
Please, find the link to the video (in Swedish) here

(15-March-2022)

Our CEO Dorte X. Gram presented our status yesterday evening including the progress with more FTE’s and API in the making

Please, find the link to the video (in English) here

(05-March-2022)

We’re very honoured that PILA PHARMA is a final nominee for the 2022 Malmö Business Award within Life Science!

Malmö Näringslivsgala

(04-March-2022)

Good summary of our progress as reported in our quarterly report plus comments from our CEO Dorte X. Gram

Vänligen läs artikeln (in Swedish) här

Please, read the article (in English) here

(03-March-2022)

We’re pleased to share this quarterly report interview with our CEO Dorte X. Gram, on our good progress. It was recorded last week when we visited some of our UK-collaborators, here, Quay Pharma in north Wales, that recently manufactured new tablets for us for use in clinical trials!

Please, find the link to the video (in English) here

(02-March-2022)

PILA PHARMA bokslutskommuniké för 1 januari – 31 december 2021
Läs rapporten PDF (in Swedish) här

(18-February-2022)

Last week, our CEO Dorte X. Gram appeared in this issue of Hälsa & Forskning distributed with Svenska Dagbladet.
Please, read the article (in Swedish) here

(07-February-2022)

Happy New Year! We’re back and looking toward an eventful 2022! 😃
Biostock has written a small summary of us and our milestones for the coming year.

Find the links below! 😃
(SWE) here
(ENG) here

(19-January-2022)

On Friday our CEO Dorte X. Gram went for a film and photo shoot here at Malmö Live Konserthus

We can’t yet disclose what for so stay tuned 🤗

(17-January-2022)

Redeye this morning published their analysis of our business case.

Please, have a look if you need guidance on assessing our risks and the overall (investment) potential (in English) here

(17-December-2021)

Contact us